UPSTREAM BIO INC

Insiders in the Hot Seat: Upstream Bio Executives Sell 700 Shares Amid Routine RSU Liquidity, Sparking Investor Speculation

Insider sell‑to‑cover moves at Upstream Bio show routine tax compliance, not a decline signal – but watch for future clinical data that could shift investor sentiment.

UPSTREAM BIO INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

17/06/2026, 22:21

3 minutes to read

Upstream Bio Executives Dump Shares Just Days Before Breakthrough Clinical Results — What It Means for Investors

Upstream Bio insider sell‑to‑cover activity signals routine tax moves, not confidence shifts, while the March 23 Phase‑2 results could spark a rally.

UPSTREAM BIO INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

17/03/2026, 22:51

2 minutes to read